- Record: found
- Abstract: not found
- Article: not found
The European Medicines Agency review of brentuximab vedotin (Adcetris) for the treatment of adult patients with relapsed or fefractory CD30+ Hodgkin lymphoma or systemic anaplastic large cell lymphoma: summary of the scientific assessment of the Committee for Medicinal Products for Human Use
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.